Tag Archives: Untitled Letter

Forest Labs Hit with Bad Ad Tattle

Forest Labs has had a tough time with regulators over the last two years. The company’s sales reps can’t seem to stop breaking the law. The latest offense, which generated an Untitled Letter from the Office of Prescription Drug Promotion (OPDP), was brought to light through OPDP’s Bad Ad program, which encourages physicians to report […]
Posted in compliance, Corporate Responsibility, FDA, Legal, Marketing, Regulatory, Sales | Also tagged , , , , , , | Leave a comment

Bristol-Myers Squibb's Summertime Blues

The sun was shining, savory scents were floating out from the grill, the lemonade was mixed and the table was set. But then dark clouds blew in and settled overhead. Bristol-Myers Squibb’s (BMS) picnic got rained out this summer. One element of the rain out was forecasted long ago; Plavix, the multibillion dollar blood-thinner, second […]
Posted in Advertising, Biotech, compliance, Deals, FDA, Legal, Marketing, pricing, R&D, Regulatory, Safety, Sales, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta